Germany’s mbiomics GmbH, a tech-bio company advancing scalable microbiome-based therapeutics for severe and chronic diseases, ...

AstraZeneca’s fixed-dose triple-combination therapy Breztri Aerosphere (budesonide/glycopyrrolate/formoterol fumarate or BGF ...

CRISPR gene editing specialist Intellia Therapeutics has announced positive topline results from the global Phase III HAELO ...

US late-stage biotech Immunic today announced that it has appointed Dr Michael Panzara as chief medical officer (CMO), ...

Profluent, the frontier AI company pioneering large-scale foundation models for protein design, today announced a ...

USA-based Ligand Pharmaceuticals and XOMA Royalty Corp, both biotechnology royalty aggregators, have entered into a ...

Swiss biopharma Idorsia (SIX: IDIA) has announced its financial results for the first quarter of 2026.

Swedish Orphan Biovitrum, also known as Sobi, reported first-quarter revenue in line with expectations, while adjusted ...

The UK is set to usher in the largest package of reforms to clinical trial regulations in more than two decades.

Swiss pharma Novartis (NOVN: VX) reported first-quarter net sales of $13.1 billion, down 1%, while core EPS fell 13% to $1.99 ...

UK-based Mundipharma and CorMedix (Nasdaq: CRMD) have reported positive Phase III data for Rezzayo (rezafungin), advancing ...

UK biotech Cerevance has reported Phase II data suggesting its Parkinson’s candidate solengepras may ease non-motor symptoms, ...